Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Sreekumar G Pillai

2PUBLICATIONS

0CO-AUTHORS

Gene expression (incl. microarray and other genome-wide approaches)Liquid biopsies

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|May 16, 2018

Coding variants in <i>PNPLA3</i> and <i>TM6SF2</i> are risk factors for hepatic steatosis and elevated serum alanine aminotransferases caused by a glucagon receptor antagonist.

Cristina B Guzman, Suman Duvvuru, Anthony Akkari

|Apr 04, 2017

Treatment with LY2409021, a glucagon receptor antagonist, increases liver fat in patients with type 2 diabetes.

Cristina B Guzman, Xiaotian M Zhang, Rong Liu

Pageof 1

Frequent Collaborators

Frequent Collaborators

Top Related Videos

Optimized Analysis of <em>In Vivo</em> and <em>In Vitro</em> Hepatic Steatosis

Optimized Analysis of <em>In Vivo</em> and <em>In Vitro</em> Hepatic Steatosis

Published on : Mar 11, 2017

See more related videos

Top Related Videos

Optimized Analysis of <em>In Vivo</em> and <em>In Vitro</em> Hepatic Steatosis

Optimized Analysis of <em>In Vivo</em> and <em>In Vitro</em> Hepatic Steatosis

Published on : Mar 11, 2017

See more related videos